Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations

Clinical trial NCT04096417 · UNKNOWN

Trial details

NCT number: NCT04096417
Sponsor: Academic and Community Cancer Research United
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

FGFR1 Gene Amplification FGFR1 Gene Mutation FGFR1 Gene Translocation FGFR2 Gene Amplification FGFR2 Gene Mutation FGFR2 Gene Translocation FGFR3 Gene Amplification FGFR3 Gene Mutation FGFR3 Gene Translocation Metastatic Colorectal Carcinoma Stage III Colorectal Cancer AJCC v8 Stage IIIA Colorectal Cancer AJCC v8

Start date: 2020-08-31
Primary completion: 2022-05-13
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.